Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/VERU-INC-37430548/news/Veru-erzielt-eine-Einigung-mit-der-FDA-uber-eine-bestatigende-klinische-Phase-3-Studie-zur-Behandl-43757202/?utm_source=whatsapp&utm_medium=social&utm_campaign=share